Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of PHAT will rise by +2.25% over the next 2 Weeks and hit $8.34 by Tuesday, September 29, 2026. In that time frame, PHAT's share price is expected to range between $7.47 and $9.30.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Sep 29, 2026 | 7.47 | 8.34 | 9.30 |
| Sep 28, 2026 | 7.20 | 8.13 | 8.97 |
| Sep 25, 2026 | 7.33 | 8.10 | 8.98 |
| Sep 24, 2026 | 7.05 | 7.93 | 8.81 |
| Sep 23, 2026 | 7.48 | 8.43 | 9.29 |
| Sep 22, 2026 | 7.50 | 8.44 | 9.34 |
| Sep 21, 2026 | 7.33 | 8.22 | 9.08 |
| Sep 18, 2026 | 7.37 | 8.19 | 9.12 |
| Sep 17, 2026 | 7.08 | 8.02 | 8.90 |
| Sep 16, 2026 | 7.64 | 8.52 | 9.34 |
PHAT shares fell -5.99% in Tuesday, September 15, 2026's trading session, dropping from a previous close of $8.68 to move at $8.16. The stock demonstrated notable intraday movement (see PHAT's key stats for a full breakdown), fluctuating between $8.10 and $8.66, a +6.85% trading range. While recent weeks have seen some volatility, PHAT has managed to secure a -13.10% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 1.63M shares changing hands, 313.3K more than the previous session. This amounted to $13.29M in total market activity.
Will PHAT Continue Its Upward Trend?
According to analyst ratings and projections for PHAT, Phathom Pharmaceuticals, Inc. shares are anticipated to increase by +12.28%, potentially reaching $9.30 per share by September 29, 2026. Short-term technical indicators currently suggest a neutral sentiment for PHAT. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 14 positive trading days within the past 30 sessions. Based on the PHAT stock forecast, now is a good time to buy PHAT stock because its current trading price is -2.20% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on PHAT covering social and institutional perspectives.
PHAT Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into PHAT's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 34.95% to 39.84%) suggest the stock is in a weak bearish momentum phase. The 50-day RSI, at 43.48%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 46.05%, maintains a neutral outlook for the long term. Insights into PHAT's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Phathom Pharmaceuticals Short-Term Forecasts
PHAT Forecast For Next 5 Days
Our algorithm anticipates Phathom Pharmaceuticals (PHAT) stock could hit $8.00 by Sep 22, 2026. This represents a -1.98% fall from today's price, following a -2.21% change over the past five days.
PHAT Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Phathom Pharmaceuticals, Inc. (PHAT) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $7.50, which would mean a -8.09% decrease from the current price of $8.16. Projections for this period range from a high of $9.13 to a low of $5.75.
PHAT Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Phathom Pharmaceuticals's price over the next three months point to a rise. PHAT stock is expected to peak at $17.33 on Sep 16, 2026 before potentially dipping to $5.97 on Dec 16, 2026. On average, PHAT is likely to trade around $11.26 in the coming 90 days.
Phathom Pharmaceuticals Stock Forecast 2025
Based on our predictive models, Phathom Pharmaceuticals (PHAT) is expected to trade between $4.60 and $17.33 throughout 2026. This would result in an average price of $10.53, potentially offering investors a +29.04% return from current levels.
Phathom Pharmaceuticals, Inc. Monthly Forecast 2026–2027
September 2026
According to our latest forecast models, Phathom Pharmaceuticals, Inc. (PHAT) is positioned to show a strong performance in September 2026. The price is predicted to move between $14.91 and $17.33, settling at an average of $16.28. This could translate to a +99.51% gain.
October 2026
Based on current market signals, Phathom Pharmaceuticals, Inc. is projected to trend october 2026. We forecast a trading range from $11.21 to $15.34, with a likely average price of $13.04. Investors could expect a potential return of +59.80%.
November 2026
Our predictive algorithms indicate Phathom Pharmaceuticals, Inc. stock may see a shift in November 2026. The expected range spans $6.77–$11.73, with an average target of $9.32. This represents a positive outlook and a possible gain of +14.22%.
December 2026
Analyzing established trends, Phathom Pharmaceuticals, Inc. looks set to move in December 2026. Projections place the stock between $4.60 and $7.59, averaging around $6.50. This suggests a -20.34% loss from current levels.
January 2027
Market indicators suggest Phathom Pharmaceuticals, Inc. could experience notable changes during January 2027. Prices could fluctuate within $2.48 to $5.83, with a midpoint forecast of $4.38. The stock might deliver a -46.32% loss.
February 2027
Forecasting for February 2027, models estimate that Phathom Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $2.76 and $6.23, averaging $5.21. This signals a cautious trajectory with potential returns around -36.15%.
March 2027
According to our latest forecast models, Phathom Pharmaceuticals, Inc. (PHAT) is positioned to show a strong performance in March 2027. The price is predicted to move between $1.63 and $5.86, settling at an average of $4.49. This could translate to a -44.98% loss.
April 2027
Based on current market signals, Phathom Pharmaceuticals, Inc. is projected to trend april 2027. We forecast a trading range from $0.58 to $3.84, with a likely average price of $3.55. Investors could expect a potential return of -56.50%.
May 2027
Our predictive algorithms indicate Phathom Pharmaceuticals, Inc. stock may see a shift in May 2027. The expected range spans $0.00–$2.66, with an average target of $2.43. This represents a cautious outlook and a possible loss of -70.22%.
June 2027
Analyzing established trends, Phathom Pharmaceuticals, Inc. looks set to move in June 2027. Projections place the stock between $0.00 and $1.70, averaging around $2.34. This suggests a -71.32% loss from current levels.
July 2027
Market indicators suggest Phathom Pharmaceuticals, Inc. could experience notable changes during July 2027. Prices could fluctuate within $0.00 to $1.49, with a midpoint forecast of $3.14. The stock might deliver a -61.52% loss.
August 2027
Forecasting for August 2027, models estimate that Phathom Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.54, averaging $2.59. This signals a cautious trajectory with potential returns around -68.26%.
September 2027
According to our latest forecast models, Phathom Pharmaceuticals, Inc. (PHAT) is positioned to show a strong performance in September 2027. The price is predicted to move between $0.00 and $0.00, settling at an average of $2.61. This could translate to a -68.01% loss.
PHAT's history of dividends and stock splits also plays a role in long-term investor confidence.